Get started
Author

Ying Wang

Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease
2025 · Landuoduo Du, Kaichuang Zhang, et al. · mSystems · 22
Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value
2025 · Luyu Wang, Hongtao Wang, et al. · Frontiers in Cellular and Infection Microbiology · 17
PDF
Impaired intestinal FXR signaling is involved in aberrant stem cell function leading to intestinal failure‐associated liver disease in pediatric patients with short bowel syndrome
2024 · Yuling Zhao, Ying Wang, et al. · The FASEB Journal · 5
Farnesoid X Receptor Agonist Tropifexor Improves Intestinal Defense Response and Epithelial Barrier Function in Neonatal Piglets Receiving Parenteral Nutrition
2025 · Yuling Zhao, Yongtao Xiao, et al. · The FASEB Journal · 1
PDF
Efficacy of a Ready-to-Feed Starter Liquid Infant Formula Containing 2-Fucosyllactose and Lacto-N-Neotetraose in Chinese Infants: Protocol for a Double Blind, Randomized Controlled Trial
2025 · Ying Wang, Caroline Ivanne Le Roy, et al. · JMIR Research Protocols · 1
PDF
Proxy‐reported quality of life of children with intestinal pseudo‐obstruction and caregivers’ self‐reported health outcomes in China
2026 · Chen Cai, Ying Wang, et al. · Journal of Pediatric Gastroenterology and Nutrition
PDF
Multi-kingdom gut microbiota analyses identify biomarkers of different types of pediatric short bowel syndrome
2026 · Qing-Qing Wu, Cheng-Yong Li, et al. · mSystems
Assessing the health-related quality of life and clinical effect in children with short bowel syndrome receiving teduglutide treatment
2026 · Fengxi Sun, Zhixuan Zhou, et al. · BMC Pediatrics
Works count: 8
Citation count: 46
H-index: 3
I10-index: 2
Year
Topic
Type